Autologous Stem Cell Treatment for Peripheral Arterial Disease [PAD]

Peripheral Arterial Disease leg schematic

University Hospital’s Case Medical Center researchers are to begin evaluating the ability of the patient’s own stem cells [autologous stem cells] to prevent leg amputations in peripheral arterial disease.  PAD effects more than 5 million adults in the US alone.  Dr. Vik Kashyap, the leading researcher, explained, “This trial offers an opportunity to save a patient’s leg when there are no remaining options to improve blood supply.”

Continue reading